MedPath

Risk Factors of liver disease in the family of Liver disease patient.

Not Applicable
Conditions
Health Condition 1: K760- Fatty (change of) liver, not elsewhere classifiedHealth Condition 2: K769- Liver disease, unspecified
Registration Number
CTRI/2019/08/020780
Lead Sponsor
Institute of Liver and Biliary Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Diagnosed cases of NASH with Cirrhosis.

2.Age >= 8 year

3.All the first degree relatives of NRC i.e index case.

4.Subject with no history of any known liver disease

5.Non-Alcoholic

6.Matched with age (+/-5 years) and gender

Exclusion Criteria

1.Acute on Chronic Liver Failure

2.Patients with HBV, HCV, Wilson, Hemochromatosis, alpha 1 antitrypsin deficiency, primary biliary cirrhosis).

3.Patient on amiodarone or tamoxifen or methotrexate.

4.Patient of malignancies other than liver.

5.Patient on chemotherapy

6.HBV related Liver Fibrosis (<= F3).

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Assessment of the risk factors for liver fibrosis among the first degree relatives of NASH related CirrhosisTimepoint: 0 day
Secondary Outcome Measures
NameTimeMethod
Assessment of the risk factors in patients with NASH related cirrhosis and Hepatitis B Virus Control.Timepoint: 0 day;Assessment of the risk factors in patients with NASH related Cirrhosis and their Healthy Control.Timepoint: 0 day;To assess the Genetic Single Nucleotide Polymorphism in NASH related Cirrhosis patients and their first degree relatives.Timepoint: 0 day;To assess the proportion of Liver fibrosis among first degree relatives of patients with NASH related Cirrhosis.Timepoint: 0 day
© Copyright 2025. All Rights Reserved by MedPath